Wall of Fame

Our CoE is very proud of our work, which is to provide high-quality science to advance the health of veterans and the nation and to ensure the patient-centered delivery of scientific discoveries.  To emphasize the high impact work of our investigators, we display the first page of publications which meet criteria listed below on our Wall of Fame, located in a common area.

Criteria Include:

First-or senior-authored peer-reviewed publications:

• Published since 2000 in a journal with an impact factor of 10 or greater OR
• Published any year in any peer-reviewed journal and cited at least 125 times OR
• Impacted clinical guidelines, health policy, or Institute of Medicine Reports

In addition, the announcement and celebration of a publication meeting the above criteria is made at our quarterly all-staff meetings as well as our bi-monthly faculty meetings.

High-Impact Publications

Since the founding of the Houston VA Health Services Research and Development CoE, its investigators have published over 900 articles; 78 were in journals with an impact factor of 10 or higher, including 10 in the New England Journal of Medicine, 5 in JAMA, 12 in Annals of Internal Medicine, 42 in Gastroenterology, 8 in Circulation, and 1 in Lancet.

The table below displays the distribution of 33 high impact publications by CoE investigators since 2003. Criteria for inclusion are: 1) CoE first- or senior-authored peer-reviewed publications published in 2000 or later in a journal with an impact factor of 10 or greater; or 2) impacting clinical guidelines, health policy, or Institute of Medicine reports; or 3) being published any year in any peer-reviewed journal and cited at least 125 times. Less than 1.15% of all publications in the Science Citation Index ever achieve this number of citations. Similarly, CoE investigators have published many papers that are seminal contributions, as reflected in their very frequent citation rate.

Publications in High-Impact Journals (ISI greater than 10.0)
and High-Frequency Citations Since 2003

Journal	Impact Factor	No. of Publications in High-Impact Journals	No. High-Frequency Citations (≥125)	No. of Publications That Impacted Clinical Guidelines, Health Policy, or Institute of Medicine Reports
New Engl J Med	51.29	5	2	1
JAMA	23.17	1
Ann Intern Med	14.78	7	3	1
Gastroenterology	12.45	10	1	1
J Clin Oncology	13.59	4		1
Circulation	10.94	3	1
Gut	9.00		1
Chest	3.92			1
Soc Sci Med	2.62		1	1

Citation of at least 125 times

• Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 2001 Apr 24;103(16):2055-9.^h
• El-Serag HB, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut 1998 Sept;43(3):327-33.
• El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. NEJM 1999 Mar;340(10):745-50.^{h, g} CITED OVER 1000 TIMES
• Kressin NR, Petersen LA. Racial differences in the use of invasive cardiovascular procedures: review of the literature and prescription for future research. Ann Intern Med 2001 Sep 4;135(5):352-66.^h
• Petersen LA, Brennan TA, O'Neil AC, Cook EF, Lee TH. Does housestaff discontinuity of care increase the risk for preventable adverse events? Ann Intern Med 1994 Dec 1;121(11):866-72.^h
• Street RL Jr. Information-giving in medical consultations: the influence of patients' communicative styles and personal characteristics. Soc Sci Med 1991;32(5):541-8.

^hArticle also has high impact factor of 10 or greater

^gArticle also impacted clinical guidelines, health policy, or Institute of Medicine Reports

High Impact Factor of 10 or greater

• Abraham NS, El-Serag HB, Johnson ML, Hartman C, Richardson P, Ray WA, Smalley W. National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs. Gastroenterology 2005 Oct;129(4):1171-8.
• Chiao E, Giordano TP, Richardson P, El-Serag HB. Human Immunodeficiency Virus-Associated Squamous Cell Cancer of the Anus: Epidemiology and Outcomes in the Highly Active Antiretroviral Therapy Era. J Clin Oncol 2008 Jan 20;26(3):474-9.
• Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 2004 Nov;127(5):1372-80.
• Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 2001 Apr 24;103(16):2055-9.^c
• El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007 Jun;132(7):2557-76.
• El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. NEJM 1999 Mar;340(10):745-50.^{c, g} CITED OVER 1000 TIMES
• El-Serag HB, Kunik M, Richardson P, Rabeneck L. Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology 2002 Aug;123(2):476-82.
• El-Serag HB, Petersen NJ, Carter J, Graham DY, Richardson P, Genta RM, Rabeneck L. Gastroesophageal reflux among different racial groups in the United States. Gastroenterology 004 Jun;126(7):1692-9.
• El-Serag HB, Inadomi JM, Kowdley KV. Screening for hereditary hemochromatosis in siblings and children of affected patients. A cost-effectiveness analysis. Ann Intern Med 2000 Feb 15;132(4):261-9.
• El-Serag HB, Gilger M, Kuebeler M, Rabeneck L. Extraesophageal associations of gastroesophageal reflux disease in children without neurologic defects. Gastroenterology 2001 Dec;121(6):1294-9.
• El-Serag HB, Everhart JE. Diabetes increases the risk of acute hepatic failure. Gastroenterology 2002 Jun;122(7):1822-8.
• El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004 Feb;126(2):460-8.
• Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005 Aug 2;143(3):199-211.
• El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003 Nov 18;139(10):817-23. Erratum in: Ann Intern Med 2004 Jan 20;140(2):151.
• Giordano TP, Henderson L, Landgren O, Chiao EY, Kramer JR, El-Serag H, Engels EA.
  Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA 2007 May 9;297(18):2010-7.
• Gordon HS, Street RL Jr, Sharf BF, Kelly PA, Souchek J. Racial differences in trust and lung cancer patients' perceptions of physician communication. J Clin Oncol 2006 Feb 20;24(6):904-9.
• Naik AD, Kallen MA, Walder A, Street RL. Improving Hypertension Control in Diabetes Mellitus The Effects of Collaborative and Proactive Health Communication. Circulation 2008 Mar 18;117(11):1361-8.
• Petersen LA, Woodard LD, Urech T, Daw C, Sookanan S. Does pay-for-performance improve the quality of health care? Ann Intern Med 2006 Aug 15;145(4):265-72.^g
• Petersen LA, Normand SL, Leape LL, McNeil BJ. Regionalization and the underuse of angiography in the Veterans Affairs Health Care System as compared with a fee-for-service system. N Engl J Med 2003 May 29;348(22):2209-17.
• Kressin NR, Petersen LA. Racial differences in the use of invasive cardiovascular procedures: review of the literature and prescription for future research. Ann Intern Med 2001 Sep 4;135(5):352-66.^c
• Petersen LA, Normand SL, Leape LL, McNeil BJ. Comparison of use of medications after acute myocardial infarction in the Veterans Health Administration and Medicare. Circulation 2001 Dec 11;104(24):2898-904.
• Petersen LA, Normand SL, Daley J, McNeil BJ. Outcome of myocardial infarction in Veterans Health Administration patients as compared with medicare patients. N Engl J Med 2000 Dec 28;343(26):1934-41.
• Petersen LA, Brennan TA, O’Neil AC, Cook EF, Lee TH. Does housestaff discontinuity of care increase the risk for preventable adverse events? Ann Intern Med 1994 Dec 1;121(11):866-72.^c
• Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 2005 Mar;128(3):620-6.
  
• Singh H, Saurabh S, Martin R, Petersen LA. Errors in Cancer Diagnosis: Current Understanding and Future Directions. Journal of Clin Onc 2007 Nov 1; 25(31):5009-18^g

^cArticle also cited at least 125 times

^gArticle also impacted clinical guidelines health policy, or Institute of Medicine Reports

Impacted Clinical Guidelines, Health Policy, or Institute of Medicine Reports

• El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. NEJM 1999 Mar;340(10):745-50.^{h, c} CITED OVER 1000 TIMES
• Kunik ME, Roundy K, Veazey C. Souchek J, Richardson P, Wray NP, Stanley MA. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest 2005 Apr;127(4):1205-11.
• Petersen LA, Woodard LD, Urech T, Daw C, Sookanan S. Does pay-for-performance improve the quality of health care? Ann Intern Med 2006 Aug 15;145(4):265-72.^h
• Singh H, Saurabh S, Martin R, Petersen LA. Errors in Cancer Diagnosis: Current Understanding and Future Directions. Journal of Clin Onc 2007 Nov 1;25(31):5009-18.^h

^hArticle also has high impact factor of 10 or greater

^cArticle also cited at least 125 times